150 related articles for article (PubMed ID: 34328007)
21. Primary Peritoneal Low-grade Serous Carcinoma in a Patient With Lynch Syndrome: A Case Report.
Makiuchi S; Yoshida H; Ishikawa M; Kojima N; Kanai Y; Kato T
Int J Gynecol Pathol; 2020 Jul; 39(4):327-332. PubMed ID: 31274699
[TBL] [Abstract][Full Text] [Related]
22. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
[TBL] [Abstract][Full Text] [Related]
23. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate Cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
Liu W; Zhang D; Tan SA; Liu X; Lai J
Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
[TBL] [Abstract][Full Text] [Related]
24. Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report.
Rkman D; Likić R; Bebek M; Gnjidić M; Gamulin M
Croat Med J; 2019 Dec; 60(6):552-555. PubMed ID: 31894921
[TBL] [Abstract][Full Text] [Related]
25. Lynch syndrome caused by a novel deletion of the promoter and exons 1-13 of MLH1 gene.
Huang J; Stinnett V; Jiang L; Chen S; Rodriguez F; Gocke CD; Zou YS
Cancer Genet; 2022 Apr; 262-263():91-94. PubMed ID: 35149321
[TBL] [Abstract][Full Text] [Related]
26. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
Stoffel EM
Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
[TBL] [Abstract][Full Text] [Related]
27. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
[TBL] [Abstract][Full Text] [Related]
28. A drug safety evaluation of atezolizumab in locally advanced or metastatic urothelial carcinoma.
Economopoulou P; Kotsantis I; Bamias A
Expert Opin Drug Saf; 2020 Aug; 19(8):955-960. PubMed ID: 32657630
[TBL] [Abstract][Full Text] [Related]
29. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
[TBL] [Abstract][Full Text] [Related]
30. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
[TBL] [Abstract][Full Text] [Related]
32. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
[TBL] [Abstract][Full Text] [Related]
33. Coexistent Dedifferentiated Endometrioid Carcinoma of the Uterus and Adenocarcinoma of the Bladder in Lynch Syndrome: Case Report and Review of the Literature.
Groth JV; Prabhu S; Periakaruppan R; Ohlander S; Emmadi R; Kothari R
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):e26-e30. PubMed ID: 32167968
[TBL] [Abstract][Full Text] [Related]
34. A Case Report of Atezolizumab Induced Tumor Lysis Syndrome.
Fa'ak F; Vanegas D; Osei KM
Am J Case Rep; 2019 Jun; 20():785-789. PubMed ID: 31160547
[TBL] [Abstract][Full Text] [Related]
35. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
36. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
[TBL] [Abstract][Full Text] [Related]
37. Recurrent Undifferentiated Carcinoma of the Sella in a Patient with Lynch Syndrome.
Voisin MR; Almeida JP; Perez-Ordonez B; Zadeh G
World Neurosurg; 2019 Dec; 132():219-222. PubMed ID: 31491579
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival in pseudo-Meigs' syndrome caused by ovarian metastases from colon cancer.
Tajima Y; Kameyama H; Yamada S; Yagi R; Nakano M; Nagahashi M; Shimada Y; Sakata J; Kobayashi T; Umezu H; Wakai T
World J Surg Oncol; 2016 Nov; 14(1):286. PubMed ID: 27842595
[TBL] [Abstract][Full Text] [Related]
39. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
40. Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study.
Petrylak DP; Powles T; Bellmunt J; Braiteh F; Loriot Y; Morales-Barrera R; Burris HA; Kim JW; Ding B; Kaiser C; Fassò M; O'Hear C; Vogelzang NJ
JAMA Oncol; 2018 Apr; 4(4):537-544. PubMed ID: 29423515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]